期刊文献+

37例高龄膀胱肿瘤患者经尿道膀胱肿瘤电切术治疗的效果评价 被引量:1

Transurethral Resection of Bladder Tumor in the Treatment of 37 Cases of Advanced Bladder Tumor
下载PDF
导出
摘要 目的探究经尿道膀胱肿瘤电切术治疗高龄膀胱肿瘤的效果。方法以来我院就医的67例高龄膀胱肿瘤患者(2012年1月—2016年6月)作为本次研究的观察对象,对67例患者的临床资料进行回顾性分析,其中37例患者实施经尿道膀胱肿瘤电切术治疗(实验组),30例患者实施传统切除手术治疗(对照组),随访半年,研究对比两组患者的手术时间、失血量及复发率。结果实验组患者失血量为(45.23±23.61)ml,相比对照组明显更少,P<0.05,但组间手术时间对比,差异无统计学意义,P>0.05;随访半年,实验组复发率为10.81%,和对照组6.67%对比,差异无统计学意义,P>0.05。结论经尿道膀胱肿瘤电切术治疗高龄膀胱肿瘤效果较显著,切实可行。 Objective To investigate the effect of transurethral resection of bladder tumor in the treatment of bladder cancer in elderly patients. Methods The clinical data of 67 patients with advanced bladder cancer(January 2012 to June 2016) treated in our hospital were analyzed retrospectively, 37 patients underwent transurethral resection of bladder tumor(experimental group), and 30 patients underwent conventional resection(control group), after half of year of follow-up, the operation time, blood loss and recurrence rate were compared between the two groups. Results The blood loss of the experimental group was(45.23±23.61) ml, which was significantly less than that of the control group, P〈0.05, however, there was no significant difference between the groups in operation time, P〉0.05, After a follow-up of half of year, the recurrence rate of the experimental group was 10.81%, which was not significantly different from that of the control group 6.67%, P〉0.05. Conclusion Transurethral resection of bladder tumor is effective and feasible for the treatment of advanced bladder tumor.
出处 《中国继续医学教育》 2017年第18期103-105,共3页 China Continuing Medical Education
关键词 经尿道膀胱肿瘤电切术 膀胱肿瘤 效果 transurethral resection of bladder tumor bladder tumor effect
  • 相关文献

二级参考文献85

  • 1孙守田,石爱平,郑显平,许宁.膀胱灌注化疗患者心理状况及干预作用[J].中国老年学杂志,2014,34(7):1964-1965. 被引量:6
  • 2张熙哲,吴新民.异丙酚靶控输注时瑞芬太尼抑制气管插管反应的半数有效血浆浓度[J].中华麻醉学杂志,2006,26(3):204-206. 被引量:46
  • 3汪向东,王希林,马弘,等.心理卫生评定量表手册[M].北京:中国心理卫生杂志社,1999.
  • 4Fehlauer F,Tribius S, Mehnert A, et al. Health-related quality of life in long term breast cancer survivors treated with breast conserving therapy: impact of age at therapy [ J ]. Breast Cancer Res Treat,2005,92(3) :217-222.
  • 5Fine PEM, Carneiro IAM, Milstein JB, Clements CJ.Issues relating to the use of BCG in immunisation preogrammes.Geneva: WHO. 1999.
  • 6Morales A,Eidinger D, Bruce AW. IntracavitaryBacillus Calmette-Guerin in the treatment of superficial bladdertumors. J Urol, 1976, 116(2):180-183.
  • 7Herr HW, Morales A. History of bacillus Calmette-Guerin and bladder cancer: an immunotherapy success story. JUrol, 2008, 179(1):53-6.
  • 8Gontero P,Bohle A, Malmstrom PU, et al. The role ofBacillus Calmette-Guerin in the treatment of non-muscle-invasive bladder cancer. Eur Urol, 2010, 57(3):410-29.
  • 9Siegel R, Ma J,Zou Z,Jemal A. Cancer Statistics,2014. CA Cancer J Clin, 2014,64(1):9-29.
  • 10Babjuk M, Burger M, Zigeuner R,et al. EAU guidelineson non-muscle-invasive urothelial carcinoma of the bladder:update 2013. Eur Urol, 2013,64(4):639-53.

共引文献143

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部